KALV Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.50%

Insider Buying (Last 12 Months): $5,234,255.35

Insider Selling (Last 12 Months): $2,706,092.82

KalVista Pharmaceuticals Insider Trading History Chart

KalVista Pharmaceuticals Share Price & Price History

^$8.43

▼ -0.1 (-1.17%)

As of 12/30/2024 01:50 PM ET

Days: 30 | 90 | 365

Kamala’s final humiliation

From Porter & Company | Ad

The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware of… yet have the potential to deliver colossal returns over the next four years. I’m not talking about Tesla, Palantir, or anything else you’ve heard parroted by the mainstream financial press. No. These are Trump’s Secret Stocks.

It’s all waiting for you here.

KalVista Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/9/2024	Benjamin L Palleiko	CEO	Sell	7,627	$9.75	$74,363.25	274,596
11/26/2024	Paul K Audhya	Insider	Sell	2,187	$9.87	$21,585.69	97,012
11/18/2024	Benjamin L Palleiko	CEO	Sell	14,400	$9.26	$133,344.00	266,598
11/18/2024	Paul K Audhya	Insider	Sell	8,077	$9.26	$74,793.02	94,199
9/9/2024	Benjamin L Palleiko	CEO	Sell	7,352	$12.19	$89,620.88	250,800
8/23/2024	Paul K Audhya	Insider	Sell	2,135	$12.40	$26,474.00	83,745
8/19/2024	Benjamin L Palleiko	CEO	Sell	14,215	$12.01	$170,722.15	242,527
8/19/2024	Christopher Yea	Insider	Sell	7,102	$12.01	$85,295.02	84,467
6/7/2024	Benjamin L Palleiko	CEO	Sell	7,465	$11.53	$86,071.45	224,547
5/20/2024	Benjamin L Palleiko	CEO	Sell	21,959	$11.76	$258,237.84	216,387
5/20/2024	Edward P. Feener	Insider	Sell	8,088	$11.76	$95,114.88	72,858
2/20/2024	Benjamin L Palleiko	CFO	Sell	22,802	$14.11	$321,736.22	187,315
2/20/2024	Edward P. Feener	Insider	Sell	28,288	$14.07	$398,012.16	62,157
2/20/2024	Thomas Andrew Crockett	CEO	Sell	24,888	$14.11	$351,169.68	211,203
2/8/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	29,747	$14.70	$437,280.90	4,824,731
2/6/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	4,474	$14.74	$65,946.76	4,743,157
1/29/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	80,600	$14.22	$1,146,132.00	4,650,584
1/26/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	4,174	$12.98	$54,178.52	4,569,984
1/24/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	20,686	$12.44	$257,333.84	4,558,780
1/22/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	67,546	$12.55	$847,702.30	4,527,197
1/18/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	39,680	$12.51	$496,396.80	4,434,651
1/16/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	19,599	$12.73	$249,495.27	4,316,046
1/11/2024	Edward P. Feener	Insider	Sell	22,679	$13.03	$295,507.37	39,828
1/10/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	47,700	$12.67	$604,359.00	4,289,800
1/8/2024	Edward P. Feener	Insider	Sell	17,221	$13.01	$224,045.21	62,607
1/8/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	69,184	$12.44	$860,648.96	4,221,284
1/3/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	17,605	$12.20	$214,781.00	4,110,336
12/29/2023	Venrock Healthcare Capital Par	Major Shareholder	Buy	6,013	$12.49	$75,102.37	4,092,731
12/27/2023	Thomas Andrew Crockett	CEO	Sell	30,000	$12.02	$360,600.00	127,532
12/27/2023	Venrock Healthcare Capital Par	Major Shareholder	Buy	41,514	$11.97	$496,922.58	3,615,228
9/11/2023	Albert Cha	Director	Sell	18,000	$10.50	$189,000.00
8/18/2023	Benjamin L Palleiko	CFO	Sell	13,067	$10.73	$140,208.91	95,254
8/18/2023	Paul K Audhya	Insider	Sell	8,020	$10.73	$86,054.60	26,023
8/18/2023	Thomas Andrew Crockett	CEO	Sell	14,876	$10.73	$159,619.48	146,756
5/18/2023	Benjamin L Palleiko	CFO	Sell	4,037	$10.14	$40,935.18	78,126
5/18/2023	Christopher Yea	Insider	Sell	2,604	$10.14	$26,404.56	37,310
5/18/2023	Thomas Andrew Crockett	CEO	Sell	5,627	$10.14	$57,057.78	128,050
2/17/2023	Benjamin L Palleiko	CFO	Sell	4,954	$7.66	$37,947.64	72,799
2/17/2023	Paul K Audhya	Insider	Sell	3,412	$7.66	$26,135.92	9,347
2/17/2023	Thomas Andrew Crockett	CEO	Sell	6,700	$7.66	$51,322.00	120,927
11/18/2022	Benjamin L Palleiko	CFO	Sell	722	$5.44	$3,927.68	68,390
11/18/2022	Christopher Yea	Insider	Sell	1,139	$5.44	$6,196.16	34,232
11/18/2022	Thomas Andrew Crockett	CEO	Sell	1,785	$5.44	$9,710.40	114,878
8/17/2022	Thomas Andrew Crockett	CEO	Sell	1,797	$14.96	$26,883.12	112,178
3/9/2022	Thomas Andrew Crockett	CEO	Sell	10,000	$17.07	$170,700.00

First JFK… next Elon?

From Porter & Company | Ad

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

SEC Filings (Institutional Ownership Changes) for KalVista Pharmaceuticals (NASDAQ:KALV)

Institutional Buying and Selling by Quarter

KalVista Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/26/2024	JPMorgan Chase & Co.	22,610	$0.26M	0.0%	+8.0%	0.046%
11/19/2024	Barclays PLC	67,222	$0.78M	0.0%	+418.5%	0.156%
11/16/2024	Geode Capital Management LLC	830,984	$9.62M	0.0%	+3.1%	1.923%
11/15/2024	Barclays PLC	67,222	$0.78M	0.0%	+418.5%	0.156%
11/15/2024	Zimmer Partners LP	95,704	$1.11M	0.0%	+52.6%	0.221%
11/15/2024	Wellington Management Group LLP	117,923	$1.37M	0.0%	+40.3%	0.273%
11/15/2024	State Street Corp	1,271,609	$14.73M	0.0%	+68.1%	2.942%
11/15/2024	Readystate Asset Management LP	180,000	$2.08M	0.0%	N/A	0.416%
11/15/2024	HighVista Strategies LLC	33,305	$0.39M	0.1%	+4.5%	0.077%
11/15/2024	Paloma Partners Management Co	17,924	$0.21M	0.0%	N/A	0.041%
11/14/2024	PDT Partners LLC	22,454	$0.26M	0.0%	N/A	0.052%
11/14/2024	Vestal Point Capital LP	4,000,000	$46.32M	3.5%	+73.9%	9.255%
11/14/2024	Suvretta Capital Management LLC	4,212,005	$48.78M	1.6%	+0.5%	9.745%
11/13/2024	Great Point Partners LLC	1,299,503	$15.05M	4.4%	-2.9%	3.007%
11/13/2024	BNP Paribas Financial Markets	43,296	$0.50M	0.0%	+1,335.5%	0.100%
11/13/2024	FMR LLC	66,423	$0.77M	0.0%	+22.9%	0.154%
11/12/2024	Citigroup Inc.	305,504	$3.54M	0.0%	+6.8%	0.707%
11/9/2024	Intech Investment Management LLC	10,855	$0.13M	0.0%	N/A	0.025%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	22,949	$0.27M	0.0%	+114.4%	0.053%
11/7/2024	First Turn Management LLC	355,000	$4.11M	0.7%	-66.5%	0.821%
11/7/2024	Quest Partners LLC	15,112	$0.18M	0.0%	N/A	0.035%
10/30/2024	Rosalind Advisors Inc.	303,864	$3.52M	2.2%	-10.1%	0.720%
10/29/2024	Emerald Advisers LLC	835,988	$9.68M	0.4%	+29.8%	1.982%
10/29/2024	Emerald Mutual Fund Advisers Trust	650,980	$7.54M	0.4%	+23.0%	1.543%
10/25/2024	China Universal Asset Management Co. Ltd.	8,286	$96K	0.0%	+67.1%	0.020%
10/3/2024	SG Americas Securities LLC	13,189	$0.15M	0.0%	N/A	0.031%
9/20/2024	Healthcare of Ontario Pension Plan Trust Fund	4,500	$53K	0.0%	-86.6%	0.011%
8/16/2024	Driehaus Capital Management LLC	535,717	$6.31M	0.1%	-1.1%	1.270%
8/15/2024	Susquehanna Fundamental Investments LLC	68,526	$0.81M	0.0%	+323.5%	0.162%
8/15/2024	The Manufacturers Life Insurance Company	15,437	$0.18M	0.0%	+27.3%	0.037%
8/15/2024	Deerfield Management Company L.P. Series C	10,841	$0.13M	0.0%	-29.4%	0.026%
8/14/2024	Great Point Partners LLC	1,338,568	$15.77M	3.0%	N/A	3.173%
8/14/2024	Marshall Wace LLP	48,911	$0.58M	0.0%	-92.2%	0.116%
8/14/2024	Evoke Wealth LLC	15,373	$0.18M	0.2%	N/A	0.036%
8/9/2024	Dimensional Fund Advisors LP	534,979	$6.30M	0.0%	-7.7%	1.268%
8/8/2024	First Turn Management LLC	1,059,540	$12.48M	2.0%	-10.2%	2.511%
8/8/2024	Nicholas Investment Partners LP	184,358	$2.17M	0.2%	+0.9%	0.437%
8/8/2024	American Century Companies Inc.	28,939	$0.34M	0.0%	-11.6%	0.069%
8/7/2024	ClariVest Asset Management LLC	57,096	$0.67M	0.1%	+2.8%	0.135%
8/6/2024	Emerald Advisers LLC	643,897	$7.59M	0.3%	-4.1%	1.507%
8/1/2024	Rhumbline Advisers	53,228	$0.63M	0.0%	+12.5%	0.125%
7/31/2024	nVerses Capital LLC	2,100	$25K	0.0%	N/A	0.005%
7/26/2024	Bank of New York Mellon Corp	135,600	$1.60M	0.0%	+21.0%	0.317%
7/26/2024	AlphaCentric Advisors LLC	2,500	$29K	0.0%	-98.1%	0.006%
7/12/2024	Rosalind Advisors Inc.	337,985	$3.98M	2.9%	+17.4%	0.801%
5/17/2024	Zimmer Partners LP	70,000	$0.83M	0.0%	N/A	0.166%
5/16/2024	California State Teachers Retirement System	3,148	$37K	0.0%	-38.2%	0.007%
5/15/2024	Price T Rowe Associates Inc. MD	22,142	$0.26M	0.0%	+4.5%	0.052%
5/15/2024	PEAK6 Investments LLC	15,000	$0.18M	0.0%	N/A	0.036%
5/14/2024	Capital World Investors	1,464,606	$17.37M	0.0%	N/A	3.471%
5/14/2024	Nan Fung Group Holdings Ltd	219,277	$2.60M	2.4%	-27.9%	0.520%
5/14/2024	EntryPoint Capital LLC	7,784	$92K	0.1%	N/A	0.018%
5/14/2024	StemPoint Capital LP	1,161,060	$13.77M	3.6%	+174.4%	2.752%
5/14/2024	Healthcare of Ontario Pension Plan Trust Fund	33,500	$0.40M	0.0%	-35.0%	0.079%
5/10/2024	Vanguard Group Inc.	1,685,113	$19.99M	0.0%	-5.4%	3.994%
5/8/2024	Entropy Technologies LP	10,172	$0.12M	0.0%	N/A	0.024%
5/7/2024	Susquehanna Fundamental Investments LLC	16,179	$0.19M	0.0%	N/A	0.038%
5/7/2024	ClariVest Asset Management LLC	55,561	$0.66M	0.1%	N/A	0.132%
5/7/2024	SG Americas Securities LLC	12,082	$0.14M	0.0%	-91.2%	0.029%
5/1/2024	BNP Paribas Financial Markets	18,013	$0.21M	0.0%	+94.5%	0.043%
4/29/2024	Principal Financial Group Inc.	10,234	$0.12M	0.0%	-11.2%	0.024%
4/29/2024	China Universal Asset Management Co. Ltd.	8,024	$95K	0.0%	+101.6%	0.019%
4/25/2024	Rosalind Advisors Inc.	287,985	$3.42M	3.2%	-4.0%	0.683%
2/15/2024	Opaleye Management Inc.	150,000	$1.84M	0.5%	-70.0%	0.434%
2/15/2024	Frazier Life Sciences Management L.P.	3,622,294	$44.37M	2.4%	+11.8%	10.481%
2/13/2024	Tower Research Capital LLC TRC	3,482	$43K	0.0%	+28.3%	0.010%
2/13/2024	Affinity Asset Advisors LLC	125,969	$1.54M	0.3%	-54.7%	0.364%
2/13/2024	Campbell & CO Investment Adviser LLC	41,365	$0.51M	0.0%	N/A	0.120%
2/6/2024	AJOVista LLC	4,920	$60K	0.1%	N/A	0.014%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	10,260	$0.13M	0.0%	N/A	0.030%
1/24/2024	China Universal Asset Management Co. Ltd.	3,981	$49K	0.0%	N/A	0.012%
1/12/2024	SG Americas Securities LLC	137,817	$1.69M	0.0%	+5.1%	0.399%
12/18/2023	Vanguard Group Inc.	1,732,489	$16.68M	0.0%	+9.6%	5.013%
11/15/2023	Adage Capital Partners GP L.L.C.	1,056,691	$10.18M	0.0%	-4.3%	3.072%
11/15/2023	Affinity Asset Advisors LLC	278,292	$2.68M	0.8%	+56.1%	0.809%
11/14/2023	MPM Bioimpact LLC	577,958	$5.57M	1.5%	-24.1%	1.680%
11/14/2023	Nan Fung Group Holdings Ltd	234,573	$2.26M	1.8%	+14.6%	0.682%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	104,668	$1.01M	0.0%	-3.1%	0.304%
11/13/2023	Algert Global LLC	23,250	$0.22M	0.0%	-11.6%	0.068%
11/13/2023	Rathbones Group PLC	19,022	$0.18M	0.0%	N/A	0.055%
11/9/2023	Citigroup Inc.	276,918	$2.67M	0.0%	-7.6%	0.805%
11/7/2023	Quantbot Technologies LP	3,200	$31K	0.0%	N/A	0.009%
11/7/2023	New York State Common Retirement Fund	9,959	$96K	0.0%	+1,860.4%	0.029%
11/7/2023	Jump Financial LLC	10,200	$98K	0.0%	-62.4%	0.030%
11/2/2023	Principal Financial Group Inc.	11,344	$0.11M	0.0%	N/A	0.033%
10/31/2023	Panagora Asset Management Inc.	22,941	$0.22M	0.0%	-12.1%	0.067%
10/26/2023	Strs Ohio	10,800	$0.10M	0.0%	N/A	0.031%
10/24/2023	Bank of New York Mellon Corp	84,309	$0.81M	0.0%	+1.8%	0.245%
10/13/2023	SG Americas Securities LLC	131,147	$1.26M	0.0%	+8.1%	0.381%
9/21/2023	Barclays PLC	4,906	$44K	0.0%	-60.5%	0.014%
8/21/2023	Affinity Asset Advisors LLC	178,292	$1.61M	0.6%	-14.4%	0.520%
8/15/2023	Silverarc Capital Management LLC	720,508	$6.49M	2.0%	-0.4%	2.105%
8/15/2023	Suvretta Capital Management LLC	2,034,506	$18.31M	1.0%	+2.6%	5.944%
8/14/2023	Jefferies Financial Group Inc.	1,030,000	$9.27M	0.1%	-14.2%	3.009%
8/14/2023	Driehaus Capital Management LLC	1,035,935	$9.32M	0.1%	+2.1%	3.026%
8/11/2023	Nan Fung Group Holdings Ltd	204,720	$1.84M	1.2%	+160.1%	0.598%
8/11/2023	Panagora Asset Management Inc.	26,090	$0.24M	0.0%	-43.6%	0.076%
8/11/2023	ExodusPoint Capital Management LP	31,180	$0.28M	0.0%	N/A	0.091%
8/10/2023	Citigroup Inc.	299,808	$2.70M	0.0%	+8.3%	0.876%
8/8/2023	AlphaCentric Advisors LLC	135,000	$1.22M	0.7%	N/A	0.394%

Data available starting January 2016

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company's product candidate is Sebetralstat, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). It develops Factor XIIa, an oral inhibitor for the treatment of HAE which is in preclinical trial. In addition, the company is developing an orally disintegrating tablet formulation, including KONFIDENT-KID for pediatric use with HAE; KONFIDENT-S for adolescent and adult patients with type I or type II HAE; and KONFIDENT for a potential oral therapy for HAE attacks. The company is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $8.43

$8.26

$8.51

50 Day Range

MA: $10.03

$8.09

$12.35

52 Week Range

Now: $8.43

$7.97

$16.88

Volume

80,257 shs

Average Volume

475,103 shs

Market Capitalization

$416.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.85

Who are the company insiders with the largest holdings of KalVista Pharmaceuticals?: KalVista Pharmaceuticals' top insider investors include:
Venrock Healthcare Capital Par (Major Shareholder)
Benjamin L Palleiko (CEO)
Thomas Andrew Crockett (CEO)
Benjamin L Palleiko (CFO)
Paul K Audhya (Insider)
Christopher Yea (Insider)
Edward P Feener (Insider)
Albert Cha (Director)
Learn More about top insider investors at KalVista Pharmaceuticals.